Literature DB >> 31414930

Just another crappy commentary: the future of fecal microbiota transplantation.

James T Rosenbaum1,2.   

Abstract

Entities:  

Keywords:  Clostridia difficile; FMT; Fecal microbiota transplant; autoimmunity; bacteria; microbiome

Mesh：

Year:  2019        PMID： 31414930      PMCID： PMC6803096          DOI： 10.1080/1744666X.2019.1656528

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN： 1744-666X            Impact factor:   4.473


× No keyword cloud information.
  34 in total

1.  Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome.

Authors:  Anne Vrieze; Els Van Nood; Frits Holleman; Jarkko Salojärvi; Ruud S Kootte; Joep F W M Bartelsman; Geesje M Dallinga-Thie; Mariette T Ackermans; Mireille J Serlie; Raish Oozeer; Muriel Derrien; Anne Druesne; Johan E T Van Hylckama Vlieg; Vincent W Bloks; Albert K Groen; Hans G H J Heilig; Erwin G Zoetendal; Erik S Stroes; Willem M de Vos; Joost B L Hoekstra; Max Nieuwdorp
Journal:  Gastroenterology       Date:  2012-06-20       Impact factor: 22.682

2.  Systematic review with meta-analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome.

Authors:  Gianluca Ianiro; Leonardo H Eusebi; Christopher J Black; Antonio Gasbarrini; Giovanni Cammarota; Alexander C Ford
Journal:  Aliment Pharmacol Ther       Date:  2019-05-28       Impact factor: 8.171

Review 3.  The role of diet on gut microbiota composition.

Authors:  S Bibbò; G Ianiro; V Giorgio; F Scaldaferri; L Masucci; A Gasbarrini; G Cammarota
Journal:  Eur Rev Med Pharmacol Sci       Date:  2016-11       Impact factor: 3.507

4.  Separating host and microbiome contributions to drug pharmacokinetics and toxicity.

Authors:  Michael Zimmermann; Maria Zimmermann-Kogadeeva; Rebekka Wegmann; Andrew L Goodman
Journal:  Science       Date:  2019-02-07       Impact factor: 47.728

5.  Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut.

Authors:  Kazuhiko Kakihana; Yuki Fujioka; Wataru Suda; Yuho Najima; Go Kuwata; Satoshi Sasajima; Iyo Mimura; Hidetoshi Morita; Daisuke Sugiyama; Hiroyoshi Nishikawa; Masahira Hattori; Yutaro Hino; Shuntaro Ikegawa; Keita Yamamoto; Takashi Toya; Noriko Doki; Koichi Koizumi; Kenya Honda; Kazuteru Ohashi
Journal:  Blood       Date:  2016-07-26       Impact factor: 22.113

6.  Antibiotic-Associated Disruption of Microbiota Composition and Function in Cirrhosis Is Restored by Fecal Transplant.

Authors:  Jasmohan S Bajaj; Genta Kakiyama; Tor Savidge; Hajime Takei; Zain A Kassam; Andrew Fagan; Edith A Gavis; William M Pandak; Hiroshi Nittono; Phillip B Hylemon; Prapaporn Boonma; Anthony Haag; Douglas M Heuman; Michael Fuchs; Binu John; Masoumeh Sikaroodi; Patrick M Gillevet
Journal:  Hepatology       Date:  2018-09-20       Impact factor: 17.425

7.  Long-Term Safety and Efficacy of Fecal Microbiota Transplant in Active Ulcerative Colitis.

Authors:  Xiao Ding; Qianqian Li; Pan Li; Ting Zhang; Bota Cui; Guozhong Ji; Xiang Lu; Faming Zhang
Journal:  Drug Saf       Date:  2019-07       Impact factor: 5.228

8.  Efficacy and safety of faecal microbiota transplantation in patients with psoriatic arthritis: protocol for a 6-month, double-blind, randomised, placebo-controlled trial.

Authors:  Maja Skov Kragsnaes; Jens Kjeldsen; Hans Christian Horn; Heidi Lausten Munk; Finn Moeller Pedersen; Hanne Marie Holt; Jens Kristian Pedersen; Dorte Kinggaard Holm; Henning Glerup; Vibeke Andersen; Ulrich Fredberg; Karsten Kristiansen; Robin Christensen; Torkell Ellingsen
Journal:  BMJ Open       Date:  2018-04-27       Impact factor: 2.692

9.  Identification of the microbial diversity after fecal microbiota transplantation therapy for chronic intractable constipation using 16s rRNA amplicon sequencing.

Authors:  Tadashi Ohara
Journal:  PLoS One       Date:  2019-03-19       Impact factor: 3.240

10.  Effect of Vegan Fecal Microbiota Transplantation on Carnitine- and Choline-Derived Trimethylamine-N-Oxide Production and Vascular Inflammation in Patients With Metabolic Syndrome.

Authors:  Loek P Smits; Ruud S Kootte; Evgeni Levin; Andrei Prodan; Susana Fuentes; Erwin G Zoetendal; Zeneng Wang; Bruce S Levison; Maartje C P Cleophas; E Marleen Kemper; Geesje M Dallinga-Thie; Albert K Groen; Leo A B Joosten; Mihai G Netea; Erik S G Stroes; Willem M de Vos; Stanley L Hazen; Max Nieuwdorp
Journal:  J Am Heart Assoc       Date:  2018-03-26       Impact factor: 5.501
View more
  1 in total

1.  Safety and efficacy of faecal microbiota transplantation by Anaerobic Cultivated Human Intestinal Microbiome (ACHIM) in patients with systemic sclerosis: study protocol for the randomised controlled phase II ReSScue trial.

Authors:  Anna-Maria Hoffmann-Vold; Håvard H Fretheim; Vikas K Sarna; Imon Barua; Maylen N Carstens; Oliver Distler; Dinesh Khanna; Elizabeth R Volkmann; Øyvind Midtvedt; Henriette Didriksen; Alvilde Dhainaut; Anne-Kristine Halse; Gunnstein Bakland; Maiju Pesonen; Inge Olsen; Øyvind Molberg
Journal:  BMJ Open       Date:  2021-06-24       Impact factor: 2.692
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.